On Tuesday, Spruce Biosciences Inc (NASDAQ: SPRB) was 4.50% up from the session before settling in for the closing price of $0.38. A 52-week range for SPRB has been $0.34 – $5.95.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
When this article was written, the company’s average yearly earnings per share was at 24.68%. With a float of $28.49 million, this company’s outstanding shares have now reached $41.30 million.
The extent of productivity of a business whose workforce counts for 29 workers is very important to gauge. In terms of profitability, gross margin is -14.36%, operating margin of -608.94%, and the pretax margin is -555.23%.
Spruce Biosciences Inc (SPRB) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Spruce Biosciences Inc stocks. The insider ownership of Spruce Biosciences Inc is 31.03%, while institutional ownership is 22.15%. The most recent insider transaction that took place on Mar 21 ’24, was worth 350,951. In this transaction 10% Owner of this company sold 465,021 shares at a rate of $0.75, taking the stock ownership to the 2,550,000 shares. Before that another transaction happened on Mar 18 ’24, when Company’s 10% Owner sold 842,020 for $0.77, making the entire transaction worth $647,008. This insider now owns 3,968,000 shares in total.
Spruce Biosciences Inc (SPRB) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 24.68% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 20.77% during the next five years compared to -22.95% drop over the previous five years of trading.
Spruce Biosciences Inc (NASDAQ: SPRB) Trading Performance Indicators
You can see what Spruce Biosciences Inc (SPRB) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 5.36. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.31.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.96, a number that is poised to hit -0.21 in the next quarter and is forecasted to reach -0.57 in one year’s time.
Technical Analysis of Spruce Biosciences Inc (SPRB)
The latest stats from [Spruce Biosciences Inc, SPRB] show that its last 5-days average volume of 0.6 million was superior to 0.54 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 62.00%. Additionally, its Average True Range was 0.03.
During the past 100 days, Spruce Biosciences Inc’s (SPRB) raw stochastic average was set at 20.61%, which indicates a significant decrease from 61.59% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 39.35% in the past 14 days, which was lower than the 66.49% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.4262, while its 200-day Moving Average is $0.5293. Now, the first resistance to watch is $0.4234. This is followed by the second major resistance level at $0.4498. The third major resistance level sits at $0.4763. If the price goes on to break the first support level at $0.3705, it is likely to go to the next support level at $0.3440. Assuming the price breaks the second support level, the third support level stands at $0.3176.
Spruce Biosciences Inc (NASDAQ: SPRB) Key Stats
There are 41,303K outstanding shares of the company, which has a market capitalization of 16.39 million. As of now, sales total 10,090 K while income totals -47,920 K. Its latest quarter income was 600 K while its last quarter net income were -8,670 K.
